137 related articles for article (PubMed ID: 9580617)
1. Effects of kappa-opioid receptor agonists on responses to colorectal distension in rats with and without acute colonic inflammation.
Burton MB; Gebhart GF
J Pharmacol Exp Ther; 1998 May; 285(2):707-15. PubMed ID: 9580617
[TBL] [Abstract][Full Text] [Related]
2. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
3. Involvement of kappa-opioid receptors in visceral nociception in mice.
Larsson MH; Bayati A; Lindström E; Larsson H
Neurogastroenterol Motil; 2008 Oct; 20(10):1157-64. PubMed ID: 18643891
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic evaluation of pressor and visceromotor reflex responses to bladder distension.
Su X; Riedel ES; Leon LA; Laping NJ
Neurourol Urodyn; 2008; 27(3):249-53. PubMed ID: 17598175
[TBL] [Abstract][Full Text] [Related]
5. Antinociceptive and adverse effects of mu- and kappa-opioid receptor agonists: a comparison of morphine and U50488-H.
Gallantine EL; Meert TF
Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):419-27. PubMed ID: 18699797
[TBL] [Abstract][Full Text] [Related]
6. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
[TBL] [Abstract][Full Text] [Related]
7. Effects of kappa opioid receptor-selective agonists on responses of pelvic nerve afferents to noxious colorectal distension.
Su X; Sengupta JN; Gebhart GF
J Neurophysiol; 1997 Aug; 78(2):1003-12. PubMed ID: 9307130
[TBL] [Abstract][Full Text] [Related]
8. Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists.
Sluka KA; Rohlwing JJ; Bussey RA; Eikenberry SA; Wilken JM
J Pharmacol Exp Ther; 2002 Sep; 302(3):1146-50. PubMed ID: 12183674
[TBL] [Abstract][Full Text] [Related]
9. Effects of kappa opioids in the inflamed rat colon.
Sengupta JN; Snider A; Su X; Gebhart GF
Pain; 1999 Feb; 79(2-3):175-85. PubMed ID: 10068163
[TBL] [Abstract][Full Text] [Related]
10. Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans.
Machelska H; Pflüger M; Weber W; Piranvisseh-Völk M; Daubert JD; Dehaven R; Stein C
J Pharmacol Exp Ther; 1999 Jul; 290(1):354-61. PubMed ID: 10381799
[TBL] [Abstract][Full Text] [Related]
11. Antinociceptive profiles of mu and kappa opioid agonists in a rat tooth pulp stimulation procedure.
Steinfels GF; Cook L
J Pharmacol Exp Ther; 1986 Jan; 236(1):111-7. PubMed ID: 2867210
[TBL] [Abstract][Full Text] [Related]
12. Effects of kappa opioid receptor agonists on attention as assessed by a 5-choice serial reaction time task in rats.
Shannon HE; Eberle EL; Mitch CH; McKinzie DL; Statnick MA
Neuropharmacology; 2007 Dec; 53(8):930-41. PubMed ID: 17959202
[TBL] [Abstract][Full Text] [Related]
13. The individual and combined effects of U50,488, and flurbiprofen axetil on visceral pain in conscious rats.
Kitamura T; Ogawa M; Yamada Y
Anesth Analg; 2009 Jun; 108(6):1964-6. PubMed ID: 19448232
[TBL] [Abstract][Full Text] [Related]
14. Colorectal distension-induced pseudoaffective changes as indices of nociception in the anesthetized female rat: morphine and strain effects on visceral sensitivity.
Sivarao DV; Langdon S; Bernard C; Lodge N
J Pharmacol Toxicol Methods; 2007; 56(1):43-50. PubMed ID: 17257861
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of mu-, delta-, and kappa-opioid receptor agonists on mechanosensitive gastric vagal afferent fibers in the rat.
Ozaki N; Sengupta JN; Gebhart GF
J Neurophysiol; 2000 Apr; 83(4):2209-16. PubMed ID: 10758129
[TBL] [Abstract][Full Text] [Related]
16. mu- but not delta- and kappa-opioid receptors in the ventrolateral orbital cortex mediate opioid-induced antiallodynia in a rat neuropathic pain model.
Zhao M; Wang JY; Jia H; Tang JS
Brain Res; 2006 Mar; 1076(1):68-77. PubMed ID: 16476416
[TBL] [Abstract][Full Text] [Related]
17. Ligands regulate cell surface level of the human kappa opioid receptor by activation-induced down-regulation and pharmacological chaperone-mediated enhancement: differential effects of nonpeptide and peptide agonists.
Chen Y; Chen C; Wang Y; Liu-Chen LY
J Pharmacol Exp Ther; 2006 Nov; 319(2):765-75. PubMed ID: 16882876
[TBL] [Abstract][Full Text] [Related]
18. Effect of the peripherally selective kappa-opioid agonist, asimadoline, on adjuvant arthritis.
Binder W; Walker JS
Br J Pharmacol; 1998 Jun; 124(4):647-54. PubMed ID: 9690855
[TBL] [Abstract][Full Text] [Related]
19. Anti-exudative effects of opioid receptor agonists in a rat model of carrageenan-induced acute inflammation of the paw.
Romero A; Planas E; Poveda R; Sánchez S; Pol O; Puig MM
Eur J Pharmacol; 2005 Mar; 511(2-3):207-17. PubMed ID: 15792790
[TBL] [Abstract][Full Text] [Related]
20. Effect of a kappa-opioid agonist, i.v. JNJ-38488502, on sensation of colonic distensions in healthy male volunteers.
Floyd BN; Camilleri M; Busciglio I; Sweetser S; Burton D; Wong GY; Kell S; Khanna S; Hwang S; Zinsmeister AR
Neurogastroenterol Motil; 2009 Mar; 21(3):281-90. PubMed ID: 18823290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
